Röhling Hanna Marie, Althoff Patrik, Arsenova Radina, Drebinger Daniel, Gigengack Norman, Chorschew Anna, Kroneberg Daniel, Rönnefarth Maria, Ellermeyer Tobias, Rosenkranz Sina Cathérine, Heesen Christoph, Behnia Behnoush, Hirano Shigeki, Kuwabara Satoshi, Paul Friedemann, Brandt Alexander Ulrich, Schmitz-Hübsch Tanja
Experimental and Clinical Research Center, a cooperation between the Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association and the Charité - Universitätsmedizin Berlin, Berlin, Germany.
Experimental and Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.
JMIR Hum Factors. 2022 Apr 1;9(2):e26825. doi: 10.2196/26825.
Instrumented assessment of motor symptoms has emerged as a promising extension to the clinical assessment of several movement disorders. The use of mobile and inexpensive technologies such as some markerless motion capture technologies is especially promising for large-scale application but has not transitioned into clinical routine to date. A crucial step on this path is to implement standardized, clinically applicable tools that identify and control for quality concerns.
The main goal of this study comprises the development of a systematic quality control (QC) procedure for data collected with markerless motion capture technology and its experimental implementation to identify specific quality concerns and thereby rate the usability of recordings.
We developed a post hoc QC pipeline that was evaluated using a large set of short motor task recordings of healthy controls (2010 recordings from 162 subjects) and people with multiple sclerosis (2682 recordings from 187 subjects). For each of these recordings, 2 raters independently applied the pipeline. They provided overall usability decisions and identified technical and performance-related quality concerns, which yielded respective proportions of their occurrence as a main result.
The approach developed here has proven user-friendly and applicable on a large scale. Raters' decisions on recording usability were concordant in 71.5%-92.3% of cases, depending on the motor task. Furthermore, 39.6%-85.1% of recordings were concordantly rated as being of satisfactory quality whereas in 5.0%-26.3%, both raters agreed to discard the recording.
We present a QC pipeline that seems feasible and useful for instant quality screening in the clinical setting. Results confirm the need of QC despite using standard test setups, testing protocols, and operator training for the employed system and by extension, for other task-based motor assessment technologies. Results of the QC process can be used to clean existing data sets, optimize quality assurance measures, as well as foster the development of automated QC approaches and therefore improve the overall reliability of kinematic data sets.
运动症状的仪器化评估已成为多种运动障碍临床评估的一种有前景的扩展方式。使用一些无标记运动捕捉技术等移动且廉价的技术对于大规模应用尤其有前景,但迄今为止尚未转化为临床常规手段。这条道路上的关键一步是实施标准化的、临床适用的工具,以识别并控制质量问题。
本研究的主要目标包括为使用无标记运动捕捉技术收集的数据开发一种系统的质量控制(QC)程序,并通过实验实施该程序以识别特定的质量问题,从而评估记录的可用性。
我们开发了一种事后QC流程,使用大量健康对照者的短运动任务记录(来自162名受试者的2010条记录)和多发性硬化症患者的记录(来自187名受试者的2682条记录)对其进行评估。对于这些记录中的每一条,两名评估者独立应用该流程。他们提供总体可用性决策,并识别与技术和性能相关的质量问题,将这些问题出现的各自比例作为主要结果。
这里开发的方法已证明对用户友好且可大规模应用。根据运动任务的不同,评估者对记录可用性的决策在71.5% - 92.3%的情况下是一致的。此外,39.6% - 85.